ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Breast Cancer

Prostate Cancer trials near Chicago, IL, USA:

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

The study is an open-label Phase 1 study of the combination of relacorilant with enzalutamide in patients with metastatic castration resistant prostate...

Active, not recruiting
Prostate Cancer
Drug: Enzalutamide
Drug: Relacorilant

Phase 1

The University of Chicago
The University of Chicago

Chicago, Illinois, United States

effectiveness of the NanoKnife System when used to ablate localized prostate cancer in intermediate risk subjects with organ-confin ...

Active, not recruiting
Prostate Cancer
Device: NanoKnife Procedure
AngioDynamics
AngioDynamics

Chicago, Illinois, United States and 1 other location

pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007

Phase 1

Janux Therapeutics

Chicago, Illinois, United States and 15 other locations

The goal of this clinical trial is to evaluate the safety of the AQUABEAM Robotic System in treating patients with localized prostate cancer...

Active, not recruiting
Localized Prostate Cancer
Device: Robotic Waterjet Treatment
PROCEPT BioRobotics

Glenview, Illinois, United States and 2 other locations

This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with recurrent prostate...

Enrolling
Biochemical Recurrence of Malignant Neoplasm of Prostate
Prostate Adenocarcinoma
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Hines, Illinois, United States and 21 other locations

single-arm, two-stage open-label phase 2 study of the combination of cabozantinib + nivolumab in subjects with advanced castration-resistant prostate...

Enrolling
Metastatic Cancer
Castration-resistant Prostate Cancer
Drug: Cabozantinib
Drug: Nivolumab

Phase 2

Rana McKay, MD

Chicago, Illinois, United States and 3 other locations

Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...

Enrolling
Prostate Adenocarcinoma
Prostate Cancer
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Hines, Illinois, United States and 16 other locations

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...

Active, not recruiting
Prostate Cancer
Biological: placebo
Drug: valacyclovir

Phase 2

Candel Therapeutics

Chicago, Illinois, United States and 22 other locations

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Sumitomo Pharma
Sumitomo Pharma

Chicago, Illinois, United States and 107 other locations

The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate...

Enrolling
Benign Prostatic Hyperplasia
Localized Prostate Cancer
Device: Robotic Waterjet Treatment
PROCEPT BioRobotics

Glenview, Illinois, United States and 4 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems